Meta Pixel

News and Announcements

FerriScan Contracted for Two New Clinical Trials

  • Published October 23, 2012 2:18AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Resonance Health has executed two multi-year contracts with a pharmaceutical company to provide FerriScan services, for an undisclosed sum.

One contract will involve Resonance Health working with up to 15 MRI facilities that will image patients participating in the clinical trial. Resonance Health will provide FerriScan image analysis services to measure liver iron concentration and a cardiac iron assessment for these patients. Resonance Health recently gained regulatory approval for the measurement of a parameter called cardiac T2* which provides an indirect assessment of cardiac iron overload.

——–

To view the full article, please click here.

 

Company Updates
Dogs First to Reduce Risk: QBiotics’ Smarter Path to Oncology Markets

QBiotics took a compound derived from a north Queensland rainforest tree all the way to veterinary registration before pursuing human oncology to de-risk its human cancer programme. Interim CEO Ebru Davidson argues that sequence – now backed by early responses across several human cancers – is the company’s real asset. The story that pulled Wholesale […]

Company Updates
Built on discipline, not complexity: inside an ASX equities income strategy

Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]

Join over 45,000+ sophisticated investors

Join Now